Schedule 13G ownership disclosure

Brickell Biotech, Inc.

Security class unavailable · CUSIP: 10802T105

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-030582
Form type
SC 13G/A
Filer
Fresh Tracks Therapeutics, Inc.
CIK
CIK 819050
Filed
Feb 11, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub